scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Dan Zhang | |
Li-Sheng Wang | |||
Wen-Bo Nie | |||
P2860 | cites work | Nanotoxicology - a pathologist's perspective | Q23909944 |
Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells | Q26747603 | ||
Journal of Cellular Biochemistry | Q6294917 | ||
Enhanced engraftment and repairing ability of human adipose-derived stem cells, conveyed by pharmacologically active microcarriers continuously releasing HGF and IGF-1, in healing myocardial infarction in rats. | Q53302437 | ||
Microencapsulated VEGF gene-modified umbilical cord mesenchymal stromal cells promote the vascularization of tissue-engineered dermis: an experimental study. | Q53637319 | ||
Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. | Q54705013 | ||
Mesenchymal Stromal Cells and Cutaneous Wound Healing: A Comprehensive Review of the Background, Role, and Therapeutic Potential. | Q55314425 | ||
Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function | Q56979828 | ||
Mesenchymal stem cells overexpressing Ang1 attenuates phosgene-induced acute lung injury in rats | Q58610424 | ||
Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity | Q60953051 | ||
Nucleic acid delivery to mesenchymal stem cells: a review of nonviral methods and applications | Q61446442 | ||
Nano-Specific Genotoxic Effects | Q62271209 | ||
Intra‐Articular Injection of Autologous Adipose Tissue‐Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo‐Controlled Clinical Trial | Q64265347 | ||
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts | Q73791469 | ||
Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector | Q81297170 | ||
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement | Q83043116 | ||
Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts | Q84149336 | ||
Improved chondrogenesis and engineered cartilage formation from TGF-β3-expressing adipose-derived stem cells cultured in the rotating-shaft bioreactor | Q84408735 | ||
Tissue Engineering Under Microgravity Conditions-Use of Stem Cells and Specialized Cells | Q88213380 | ||
Current Status of Stem Cell Therapies in Tissue Repair and Regeneration | Q88587133 | ||
Bone Marrow-Derived and Adipose-Derived Mesenchymal Stem Cell Therapy in Primary Knee Osteoarthritis: A Narrative Review | Q90231012 | ||
Stem cell-based regenerative medicine for neurological disorders: A special tribute to Dr. Teng Ma | Q90760509 | ||
MSC-secreted TGF-β regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt/FoxO1 pathway | Q91471027 | ||
Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells | Q91540791 | ||
Intra-arterial injection of human adipose-derived stem cells improves viability of the random component of axial skin flaps in nude mice | Q91652840 | ||
Angiopoietin-1 accelerates restoration of endothelial cell barrier integrity from nanoparticle-induced leakiness | Q91682047 | ||
Cell therapy to improve regeneration of skeletal muscle injuries | Q92184890 | ||
Three-dimensional spheroids of mesenchymal stem/stromal cells promote osteogenesis by activating stemness and Wnt/β-catenin | Q92284888 | ||
VEGF and FGF-2: Promising targets for the treatment of respiratory disorders | Q92673931 | ||
Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens | Q92827333 | ||
Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Renal Diseases | Q92924422 | ||
Stem cell-based regenerative medicine | Q92969530 | ||
A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods | Q26998969 | ||
Engineering mesenchymal stem cells for regenerative medicine and drug delivery | Q27026414 | ||
Genetically modified mesenchymal stromal cells in cancer therapy | Q28071840 | ||
Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
Adipose tissue-derived stem cells secrete CXCL5 cytokine with neurotrophic effects on cavernous nerve regeneration | Q28583906 | ||
Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells | Q28730445 | ||
Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1 | Q28757126 | ||
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche | Q29616602 | ||
Mesenchymal stem cells as trophic mediators | Q29619806 | ||
High-throughput screening for modulators of mesenchymal stem cell chondrogenesis | Q33369436 | ||
Development of a hybrid baculoviral vector for sustained transgene expression | Q33713396 | ||
Ethical issues in stem cell research and therapy | Q33900583 | ||
Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats | Q33953066 | ||
Therapeutic potential of genetically modified adult stem cells for osteopenia | Q34137317 | ||
Growth factor regulation of proliferation and survival of multipotential stromal cells | Q34318054 | ||
Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation | Q34442918 | ||
Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models | Q34500223 | ||
Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. | Q34545357 | ||
Hepatocyte growth factor gene-modified adipose-derived mesenchymal stem cells ameliorate radiation induced liver damage in a rat model. | Q34689652 | ||
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial | Q34979725 | ||
Fetal vs adult mesenchymal stem cells achieve greater gene expression, but less osteoinduction | Q34992010 | ||
Hepatocyte growth factor modification enhances the anti-arrhythmic properties of human bone marrow-derived mesenchymal stem cells | Q35381753 | ||
Virus integration and genome influence in approaches to stem cell based therapy for andro-urology | Q35433757 | ||
HGF Gene Modification in Mesenchymal Stem Cells Reduces Radiation-Induced Intestinal Injury by Modulating Immunity | Q35560905 | ||
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. | Q36411255 | ||
Gene-modified mesenchymal stem cells protect against radiation-induced lung injury | Q36673719 | ||
Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models. | Q36939755 | ||
Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines | Q37017086 | ||
Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic | Q37035997 | ||
Combined administration of mesenchymal stem cells overexpressing IGF-1 and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model. | Q37099897 | ||
A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats | Q37117849 | ||
Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy | Q37200247 | ||
Virus-mimetic cytoplasm-cleavable magnetic/silica nanoclusters for enhanced gene delivery to mesenchymal stem cells | Q37352200 | ||
Mesenchymal Stem Cells Combined with Hepatocyte Growth Factor Therapy for Attenuating Ischaemic Myocardial Fibrosis: Assessment using Multimodal Molecular Imaging | Q37386157 | ||
A systematic review of mesenchymal stem cells in spinal cord injury, intervertebral disc repair and spinal fusion | Q50165304 | ||
Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods. | Q50610411 | ||
Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction. | Q50688387 | ||
Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. | Q50981151 | ||
TGF-β1 gene-engineered mesenchymal stem cells induce rat cartilage regeneration using nonviral gene vector. | Q51068121 | ||
HucMSC-Exosome Mediated-Wnt4 Signaling Is Required for Cutaneous Wound Healing. | Q51072021 | ||
A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. | Q51638885 | ||
Randomized Assessment of the Safety and Efficacy of Intra-Arterial Infusion of Autologous Stem Cells in Subacute Ischemic Stroke. | Q52653365 | ||
Recent Progress in Stem Cell Modification for Cardiac Regeneration. | Q52657125 | ||
Transplantation of bone marrow stromal cells overexpressing human vascular endothelial growth factor 165 enhances tissue repair in a rat model of radiation-induced injury. | Q53062862 | ||
Exosomes from differentiating human skeletal muscle cells trigger myogenesis of stem cells and provide biochemical cues for skeletal muscle regeneration. | Q53233772 | ||
Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage. | Q37628097 | ||
Modification of mesenchymal stem cells for cardiac regeneration. | Q37687406 | ||
Non-viral gene delivery to mesenchymal stem cells: methods, strategies and application in bone tissue engineering and regeneration. | Q37823610 | ||
The potential use of mesenchymal stem cells in stroke therapy--From bench to bedside | Q38394441 | ||
MSC-based VEGF gene therapy in rat myocardial infarction model using facial amphipathic bile acid-conjugated polyethyleneimine. | Q38444170 | ||
Cellular and molecular mechanisms of HGF/Met in the cardiovascular system. | Q38631649 | ||
Mesenchymal Stem Cell-Derived Exosomes Promote Fracture Healing in a Mouse Model | Q38755589 | ||
Bone Tissue Regeneration - Application of Mesenchymal Stem Cells and Cellular and Molecular Mechanisms | Q38961845 | ||
Safety of Intra-Arterial Injection With Tumor-Activated T Cells to the Rabbit Brain Evaluated by MRI and SPECT/CT. | Q39304787 | ||
Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration. | Q39452218 | ||
Hepatocyte growth factor-modified mesenchymal stem cells improve ischemia/reperfusion-induced acute lung injury in rats | Q39458079 | ||
Overexpression of lentivirus-mediated glial cell line-derived neurotrophic factor in bone marrow stromal cells and its neuroprotection for the PC12 cells damaged by lactacystin | Q40115203 | ||
Minicircle microporation-based non-viral gene delivery improved the targeting of mesenchymal stem cells to an injury site. | Q40695017 | ||
Mesenchymal stem cells modified with angiopoietin-1 gene promote wound healing | Q42240202 | ||
Protection against radiation-induced hematopoietic damage in bone marrow by hepatocyte growth factor gene transfer | Q42267602 | ||
HGF potentiates extracellular matrix-driven migration of human myoblasts: involvement of matrix metalloproteinases and MAPK/ERK pathway | Q42374498 | ||
Transplantation of BMSCs expressing hPDGF-A/hBD2 promotes wound healing in rats with combined radiation-wound injury | Q43482170 | ||
Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats. | Q43608224 | ||
Effects of adenovirus-mediated delivery of the human hepatocyte growth factor gene in experimental radiation-induced heart disease | Q43774404 | ||
Cell transplantation of 5-aza cytidine induced bone marrow stromal cells transfected by angiogenin gene ex vivo into infarcted myocardium, an experimental study | Q44268032 | ||
New tools in regenerative medicine: gene therapy | Q44477989 | ||
Protective effects of BDNF overexpression bone marrow stromal cell transplantation in rat models of traumatic brain injury | Q44481907 | ||
Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction | Q44828167 | ||
Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury | Q45125233 | ||
Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats. | Q45422591 | ||
Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration | Q45858015 | ||
Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction | Q45859388 | ||
Adeno-associated viral vector transduction of human mesenchymal stem cells. | Q45868527 | ||
Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice | Q45874639 | ||
Human fetal mesenchymal stem cells as vehicles for gene delivery | Q45880334 | ||
MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis | Q45881843 | ||
Research on promoting periodontal regeneration with human basic fibroblast growth factor-modified bone marrow mesenchymal stromal cell gene therapy | Q45884064 | ||
Twist-1 Enhances Bone Marrow Mesenchymal Stromal Cell Support of Hematopoiesis by Modulating CXCL12 Expression | Q46144641 | ||
Study on the levels of DA and metabolite in striatum in rats with Parkinson's disease treated by BDNF gene modified bone mesenchymal stem cells | Q46364753 | ||
Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction | Q46374324 | ||
Cytokine interactions in mesenchymal stem cells from cord blood | Q46867746 | ||
High insulin-induced down-regulation of Erk-1/IGF-1R/FGFR-1 signaling is required for oxidative stress-mediated apoptosis of adipose-derived stem cells. | Q46895204 | ||
The limited application of stem cells in medicine: a review | Q47134432 | ||
BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. | Q47226339 | ||
Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia | Q47230275 | ||
Human cardiac multipotent adult stem cells in 3D matrix: new approach of tissue engineering in cardiac regeneration post-infarction | Q47237278 | ||
Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells | Q47403404 | ||
Transplantation of Hepatocyte Growth Factor-Modified Dental Pulp Stem Cells Prevents Bone Loss in the Early Phase of Ovariectomy-Induced Osteoporosis. | Q47761394 | ||
Stem Cell-Derived Extracellular Vesicles as a Novel Potential Therapeutic Tool for Tissue Repair | Q48218729 | ||
Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. | Q48682582 | ||
Hepatocyte Growth Factor Gene Therapy for Ischemic Diseases and Tissue Regeneration | Q50157955 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | mesenchymal stem cell | Q1922379 |
P304 | page(s) | 1241-1256 | |
P577 | publication date | 2020-03-26 | |
P1433 | published in | Drug Design, Development and Therapy | Q2566724 |
P1476 | title | Growth Factor Gene-Modified Mesenchymal Stem Cells in Tissue Regeneration | |
P478 | volume | 14 |